Congratulations to Mammoth Biosciences for signing a more than $1 billion collaboration agreement with Bayer to unlock the full potential of ultra-small CRISPR systems→

Bayer and Mammoth Biosciences today announced a strategic collaboration and option agreement for the use of Mammoth’s CRISPR systems to develop in vivo gene-editing therapies

Read More —>